InsidersTradesSigma
Browse the detailed record of transactions filed by Maynard Ryan D, Director. Officer active across 1 companies, notably Iovance Biotherapeutics, INC.. Aggregated, 1 reports have been recorded. Total volume traded: €47k. The latest transaction was disclosed on 31 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
1 of 1 declaration
Ryan D. Maynard is a Director of IOVANCE BIOTHERAPEUTICS, INC. As a board member, he contributes to the governance and strategy of the company. His experience in the biopharmaceutical sector is valuable for IOVANCE.